Isolation, Crystal Structure and Cytotoxic Activity of Natural Maistemonine and Comparison with the Synthetic Compound

Yi WU Qing-Mei YE Shu-Qin QIN Ren-Wang JIANG

Citation:  Yi WU, Qing-Mei YE, Shu-Qin QIN, Ren-Wang JIANG. Isolation, Crystal Structure and Cytotoxic Activity of Natural Maistemonine and Comparison with the Synthetic Compound[J]. Chinese Journal of Structural Chemistry, 2020, 39(7): 1277-1282. doi: 10.14102/j.cnki.0254–5861.2011–2698 shu

Isolation, Crystal Structure and Cytotoxic Activity of Natural Maistemonine and Comparison with the Synthetic Compound

English

  • Radix Stemonae derived from the roots of Stemona tuberosa, S. japonica and S. sessilifolia (Stemonaceae family) are often used as an antitussive Traditional Chinese Medicine to treat respiratory disorders[1]. The alkaloids possessing the nucleus of pyrrolo-azepine are the major components responsible for the antitussive activity[2, 3].

    Maistemonine had ever been isolated from Stemona pierrei[4], S. sessilifolia[5] and S. japonica[6]. This alkaloid was found to show significant antitussive activity in a citric acid-induced guinea pig cough model following peripheral administration[5]. Quantitative determination of maistemonine was achieved by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors[7]. Due to the intriguing structure and pronounced antitussive activity, total synthesis of (±)-maistemonine was reported[8]. However, the crystal structure of natural maistemonine has not been reported yet.

    Our group has been engaged in Stemona alkaloids for many years[9-13]. A series of alkaloids were identified from S. tuberosa, and some of them were found to show antitussive activities[14, 15]. During our further systematic investigation of alkaloids from Stemona genus, the chemical constituents of S. japonica were studied. Maistemonine (1, Scheme 1) was isolated and crystallized in a mixture solution of n-hexane and ethyl acetate. 1 was reported to show antitussive activity[5] and chemically synthesized[8]. Compound 1 has five chiral centers (C(2), C(4), C(6), C(9) and C(17)), and a precise understanding of their three-dimensional structures would be important for understanding the bioactivities. We report herein the isolation, crystal structure and cytotoxic activity of compound 1 and a detailed comparison with the synthetic compound.

    Scheme 1

    Scheme 1.  Structures of maistemonine (1) and isomaistemonine (2)

    Melting points were determined using a Fisher scientific and uncorrected. The UV spectra were obtained on a Beckman Du650 spectrophotometer in MeOH. IR spectra were recorded on a Nicolet impact 420 FT-IR spectrometer. The NMR spectra were obtained on a Bruker 400 spectrometer with chemical shift reported in δ (ppm) using TMS as the internal stand. ESIMS was recorded on a Finnigan MAT TSQ 7000 instrument. X-ray diffraction of compound 1 was conducted on a Bruker SMART1000 CCD diffractometer.

    Roots of Stemona japonica were collected in Yunnan province, and were identified by Prof. Guangzhou Zhou in College of Pharmacy, Jinan University. A voucher specimen (SJ-2004) is deposited in College of Pharmacy, Jinan University.

    A dry ground herbal sample of the roots S. japonica (1.0 kg) was percolated with 95% EtOH at room temperature for three days, and then the solution was filtered and concentrated under reduced pressure to afford a residue (86 g). The residue was acidified with 500 mL of 4% HCl solution, and then extracted with Et2O (400 mL × 3). The Et2O layer was evaporated to give a crude non-alkaloid extract (6 g). The pH value of the water layer was adjusted to 9.0 with 35% NH4OH, and extracted with Et2O to afford the total alkaloids (4.5 g). The total alkaloids (4.0 g) were subjected to preparative HPLC eluted by gradient H2O-CH3CN containing 0.1% Et3N. The peak at Rt = 15.7 min was collected and condensed under vacuo to afford maistemonine (1, 18 mg). Finally, the maistemonine was re-crystallized from a mixture of n-hexane-ethyl acetate (3:1) to afford colorless crystals.

    Compound 1: C23H29NO6, m. p.: 204~205 ℃, UV (MeOH) λmax 260 nm; IR (KBr) vmax 1710, 1758 cm-1. ESI-MS 416.2 [M+H] +, 317.3 [M+H-C5H7O2] +.

    The crystals suitable for X-ray structure determination were obtained by slow evaporation of n-hexane and ethyl acetate mixture (3:1) at room temperature. A colorless prism-like crystal of the title compound with dimensions of 0.15mm × 0.12mm × 0.10mm was selected and mounted on a thin glass fiber. Intensity data were collected at room temperature (292(2) K) on a Smart1000 CCD diffractometer using Mo radiation λ = 0.71079 Å. The data frames with a maximum 2θ value of ~55.8° were processed using the program SAINT. The data were corrected for absorption and beam corrections based on the multi-scan technique as implemented in SADABS.

    A total of 5136 reflections were collected in the range of 1.8≤θ≤27.9° (index ranges: –10≤h≤11, –14≤k≤18, –23≤l≤23) by using an ω scan mode, of which 3523 independent reflections (Rint = 0.061) with I > 2σ(I) were considered as observed and used in the succeeding refinements. The structure was solved by direct methods with SHELXS-2014 and expanded by using Fourier difference techniques. The non-hydrogen atoms were refined anisotropically, and the hydrogen atoms were added according to theoretical models. The structure was refined by full-matrix least-squares techniques on F2 with SHELXL-2014. The final refinement gave R = 0.0535, wR = 0.1067 (I > 2σ(I)), w = 1/[σ2(Fo2) + (0.0558P)2 + 0.0000P], where P = (Fo2 + 2Fc2)/3. (Δ/σ)max = 0.000, S = 0.995, (∆ρ)max = 0.156 and (∆ρ)min = –0.176 e/Å3.

    The MTT assay was done according to the procedures described previously[16] with cisplatin serving as the positive control. Briefly, the prostate cancer cells were plated into 96-well plates at a density of 3 × 103 cells per well for androgen independent cells DU145 and 5 × 103 cells per well for androgen dependent cell PC3 cells. After 48 h of exposure, staining with 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) was performed. The IC50 values were calculated based on the absorbance at 570 nm which was measured on a multiplate reader.

    Compound 1 was obtained from the total alkaloid fraction of the 95% ethanol extract followed by preparative HPLC (detection at 260 nm, Fig. 1). The peak at 15.7 min was collected, concentrated under reduced pressure and recrystallized as colorless prism-like crystals. High resolution ESIMS analysis of 1 showed a quasi-molecular ion peak at [M+H]+ 416.2060, corresponding to a molecular formula C23H30NO6 (calculated 416.2068). Its IR spectrum (KBr) showed the presence of two γ-lactone rings (1710, 1758 cm–1). The ESI mass spectrum showed [M+H]+ at m/z 416.2 and the base peak at m/z 317.3 [M+H-C5H7O2]+, indicating the presence of typical β-methyl-γ-lactone ring annexed to C(3) of the azepine ring.

    Figure 1

    Figure 1.  HPLC chromatogram of total alkaloid of S. japonica, showing the presence of maistemonine (1) and the highest peak protostemonine. Column: C 18 column (Alltech, 250 × 4.6 cm, 5 μm); mobile phase: (A) H2O-(B) CH3CN containing 0.1% Et3N, gradient: 0~10 min isocratic 40% B, 10~12 min linear 40% to 50% of B; 12~28 min isocratic 50% B and 28~30 min linear 50% to 40% of B; flow rate: 1.0 mL/min; detection: 260 nm

    The 1H-NMR spectrum of compound 1 showed a doublet (d, J = 7.2 Hz, 3H) at δH 1.24 for the C(5) methyl group, two singlets (s, 3H each) at δH 2.06, corresponding to the two methyl groups on a double bond C(18) and C(22), a singlet at δH 4.00 (s, 3H, H-23) attributed to a methoxy group and a low-field proton attached to carbon atoms bearing an oxygen function at δH at 3.85 (ddd, J = 6.0, 7.8, 11.2 Hz, 1H, H-4), a methine and two geminal protons attached to carbon atoms bearing a nitrogen function at δH 3.59 (m, 1H, H-6), δH 3.38 (m, 1H, H-14β) and δH 2.90 (m, 1H, H-14α). The 13C-NMR spectrum showed a saturated lactone ring (δC 179.5, 34.2, 34.1, 84.7), an α,β-unsaturated lactone ring (δC 175.2, 97.0, 172.0, 91.5) and an α,β-unsaturated ketone ring (δC 196.8, 135.0, 175.1, 79.6, 91.5). These spectroscopic data are reminiscent of the protostemonine-type alkaloids bearing an α-methyl-γ-lactone ring annexed to C-3[3].

    The crystal belongs to orthorhombic system with space group P212121. Selected bond lengths and bond angles of compound 1 are given in Table 1. Fig. 2 shows the molecular structure of the title compound, and Fig. 3 depicts the packing diagram. X-ray analysis confirmed the presence of an α,β-unsaturated lactone ring (A), a α,β-unsaturated ketone ring (B), a tetrahydropyrrole ring (C), a seven-membered hetercyclic ring (D), and a saturated lactone ring (E).

    Table 1

    Table 1.  Selected Bond Lengths (Å) and Bond Angles (°)
    DownLoad: CSV
    Bond Dist. Bond Dist.
    O(1)–C(1) 1.199(3) O(5)–C(19) 1.208(4)
    O(2)–C(1) 1.365(3) O(6)–C(21) 1.334(3)
    O(2)–C(4) 1.453(3) O(6)–C(23) 1.434(4)
    O(3)–C(16) 1.218(4) N(1)–C(14) 1.455(3)
    O(4)–C(19) 1.374(4) N(1)–C(6) 1.460(3)
    O(4)–C(17) 1.430(3) N(1)–C(9) 1.466(3)
    Angle (°) Angle (°)
    C(14)–N(1)–C(6) 118.2(2) N(1)–C(9)–C(17) 113.2(2)
    C(14)–N(1–C(9) 120.6(2) C(10)–C(9)–C(17) 101.8(2)
    C(6)–N(1)–C(9) 111.8(2) C(8)–C(9)–C(17) 110.9(2)
    O(2)–C(4)–C(6) 111.4(2) C(15)–C(10)–C(11) 126.2(3)
    O(2)–C(4)–C(3) 103.6(2) C(15)–C(10)–C(9) 112.3(3)
    C(6)–C(4)–C(3) 114.3(2) C(11)–C(10)–C(9) 121.1(3)
    N(1)–C(6)–C(4) 113.8(2) O(4)–C(17)–C(21) 103.4(2)
    N(1)–C(6)–C(7) 104.1(2) O(4)–C(17)–C(16) 112.5(2)
    C(4)–C(6)–C(7) 108.4(2) C(21)–C(17)–C(16) 109.8(2)
    N(1)–C(9)–C(10) 117.7(2) O(4)–C(17)–C(9) 112.7(2)
    N(1)–C(9)–C(8) 104.3(2) C(21)–C(17)–C(9) 115.6(2)
    C(10)–C(9)–C(8) 109.0(2) C(16)–C(17)–C(9) 103.1(2)

    Figure 2

    Figure 2.  Molecular structure of 1, showing 30% probability displacement ellipsoids and the atom-numbering scheme

    Figure 3

    Figure 3.  A packing diagram for compound 1 viewed roughly down the a-axis. Selected hydrogen atoms highlight the scheme of hydrogen bonds

    Ring A is planar with the mean derivation of 0.0123(4) Å. The five-membered rings B, C and E all adopt envelope conformations with C(17), C(7) and C(3) displaced by –0.3583(2), 0.5325(3) and –0.5535(2) Å from the mean planes of the remaining four atoms in each ring, respectively. The seven-membered heterocyclic ring D adopts a chair conformation with N(1), C(9) and C(12) deviating by –1.0236, –0.8973 and 0.6996 Å from the least-squares plane (C(10), C(11), C(13) and C(14)), respectively. Rings A and B are connected through a spiro-atom C(17) and are roughly perpendicular to each other with a dihedral angle 88.1°.

    The relative configurations of the chiral centers C(2), C(4), C(6), C(9) and C(17) were established to be rel-(S, S, S, S and S), respectively, and both the C(10)–C(15) and C(20–C(21) double bonds are E-configurations. Compound 1 is an isomer of isomaistemonine (2) at C(17), which can be synthesized from 1 through a retro-Mannich process[8]. It is here named maistemonine. Due to the absence of heavy atom in the molecule, the final refinement resulted in a non-significant Flack parameter; however, considering the conserved α-orientated methyl group at C(2) in Stemona alkaloids[3, 12], the absolute configuration of compound 1 could be assigned as shown in Fig. 2.

    No typical intermolecular hydrogen bonds were found in the crystal structure. In solid state, intermolecular weak C–H…O interactions[17] (Table 2) linked the molecules into a three-dimensional assembly (Fig. 3).

    Table 2

    Table 2.  Intermolecular C–H···O Interaction[17] Lengths (Å) and Angles (°)
    DownLoad: CSV
    D–H···A d(D–H) d(H···A) d(D···A) ∠DHA
    C(14)–H(14A)···O(6) 0.97 2.36 3.147(4) 138
    C(14)–H(14B)···O(2) 0.97 2.36 3.070(4) 130
    C(3)–H(3A)···O(5)a 0.97 2.66 3.581(3) 159
    C(3)–H(3B)···O(3)b 0.97 2.73 3.494(4) 136
    C(22)–H(22A)···O(2)c 0.96 2.81 3.467(2) 126
    C(18)–H(18A)···O(1)d 0.96 2.72 3.430(3) 131
      Symmetry codes: (a) x – 1, y, z; (b) 1.5 – x, 1 – y, z – 0.5; (c) x + 1, y, z; (d) 1 – x, y + 0.5, 1.5 – z

    The synthesis of natural products offers a reliable way to confirm the complete structure of natural products; however, most natural products are chiral and the synthetic compounds are often racemic. For the natural alkaloid 1, the absence of h00, 0k0 and 00l reflections when h, k, and l are odd numbers clearly indicated space group P212121. In contrast, for the corresponding synthetic compound[8], the crystal belongs to triclinic system with space group P1. Furthermore, significant conformational changes were observed in the lactone ring E (Fig. 4), which were evidenced by the torsion angles of N(1)–C(6)–C(4)–O(2) (63.7°) and N(1)–C(6)–C(4)–C(3) (–179.2°) for the natural 1, in contrast to the corresponding angles from the synthetic compound (–173.5° and –54.8°, respectively). When overlapping A, B, C and D rings of the natural and synthetic compound, rings E from the two compounds are almost perpendicular to each other (Fig. 4).

    Figure 4

    Figure 4.  Overlap of the natural 1 (with atom labels) and the synthetic compound with Olex 2 software. When overlapping A, B, C and D rings of the natural and synthetic compound, rings E from the two compounds are almost perpendicular to each other. For clarity, only ring E of the natural 1 was labeled

    Besides the antitussive activity, the cytotoxicity[4] and anti-insect properties[18] of Stemona alkaloids were often investigated. The antitussive activity of 1 have been reported before[5]. The cytotoxic property of 1 was evaluated herein which was studied using a standard MTT procedure[16]. Compound 1 shows mild cytotoxic activity against the prostate cancer cells LNCaP (an androgen dependent prostate cancer cell) and PC3 (an androgen independent prostate cancer cell) with the IC50 values of 29.4 ± 2.3 and 46.6 ± 3.1 μM, respectively, which are around three times weaker than the positive control cisplatin (10.1 ± 1.3 for LNCaP cells and 15.4 ± 1.6 μM for PC3 cells).

    In summary, we report herein the crystal structure of maistemonine (1), which is a natural product isolated from the roots of Stemona japonica. We found that the natural maistemonine is completely different from the corresponding synthetic compound because the former is chiral while the latter is racemic. Furthermore, the E-rings of the natural product and the synthetic compound showed completely different orientation, suggesting that artificial synthesis is difficult to replace the natural sources. It is noteworthy that the cytotoxic activity is reported here for the first time.

    We declare that this work was done by the authors named in this article. Jiang Ren-Wang designed the study and the experiments. Wu Yi performed the isolation and identification of maistemonine, Ye Qing-Mei performed the bioassay on the inhibitory activities of maistemonine on cancer cells and Qin Shu-Qin carried out the X-ray crystallographic analysis of maistemonine.


    1. [1]

      Pharmacopoeia commission of People's Republic of China. The Pharmacopoeia of the People's Republic of China, Part 1. Chemical Industry Publishing House, Beijing, China 2015, p204.

    2. [2]

      Pilli, R. A.; Rossoa, G. B.; Oliveira, M. C. The chemistry of Stemona alkaloids: an update. Nat. Prod. Rep. 2010, 27, 1908–1937. doi: 10.1039/c005018k

    3. [3]

      Greger, H. Structural relationships, distribution and biological activities of Stemona alkaloids. Planta Med. 2006, 72, 99–113. doi: 10.1055/s-2005-916258

    4. [4]

      Quang, D. N.; Khamko, V. A.; Trang, N. T.; Yen, L. T. H.; Dien, P. H. Stemofurans X-Y from the roots of Stemona species from Laos. Nat. Prod. Commun. 2014, 9, 1741–1742.

    5. [5]

      Yang, X. Z.; Zhu, J. Y.; Tang, C. P.; Ke, C. Q.; Lin, G.; Cheng, T. Y.; Rudd, J. A.; Ye, Y. Alkaloids from roots of Stemona sessilifolia and their antitussive activities. Planta Med. 2009, 75, 174–177. doi: 10.1055/s-0028-1088345

    6. [6]

      Yi, M.; Xia, X.; Wu, H. Y.; Tian, H. Y.; Huang, C.; But, P. P. H.; Shaw, P. C.; Jiang, R. W. Structures and chemotaxonomic significance of stemona alkaloids from Stemona japonica. Nat. Prod. Commun. 2015, 10, 2097–2099.

    7. [7]

      Li, S. L.; Jiang, R. W.; Hon, P. M.; Cheng, L.; Xu, H. X.; Greger, H.; But, P. P. H.; Shaw, P. C. Quality evaluation of Radix Stemonae through simultaneous quantification of bioactive alkaloids by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors. Biomed. Chromatogr. 2007, 21, 1088–1094. doi: 10.1002/bmc.862

    8. [8]

      Chen, Z. H.; Chen, Z. M.; Yang, Y. Q.; Tu, Y. Q.; Zhang, F. M. Total synthesis of (±)-maistemonine, (±)-stemonamide, and (±)-isomaistemonine. J. Org. Chem. 2011, 76, 10173–10186. doi: 10.1021/jo202042x

    9. [9]

      Jiang, R. W.; Hon, P. M.; But, P. P. H.; Chung, H. S.; Lin, G.; Ye, W. C.; Mak, T. C. W. Isolation and stereochemistry of two new alkaloids from Stemona tuberose Lour. Tetrahedron 2002, 58, 6705–6712. doi: 10.1016/S0040-4020(02)00678-6

    10. [10]

      Jiang, R. W.; Hon, P. M.; Xu, Y. T.; Chan, Y. M.; Xu, H. X.; Shaw, P. C.; But, P. P. H. Isolation and chemotaxonomic significance of tuberostemospironine-type alkaloids from Stemona tuberosa. Phytochemistry 2006, 67, 52–57. doi: 10.1016/j.phytochem.2005.10.004

    11. [11]

      Wu, Y.; Ye, Q. M.; Liu, J.; Xu, W.; Zhu, Z. R.; Jiang, R. W. Isolation, crystal structure and antitussive activity of 9S, 9aS-neotuberostemonine. Chin. J. Struct. Chem. 2018, 37, 571–576.

    12. [12]

      Jiang, R. W.; Hon, P. M.; Zhou, Y.; Chan, Y. M.; Xu, Y. T.; Xu, H. X.; Greger, H.; Shaw, P. C.; But, P. P. H. Alkaloids and chemical diversity of Stemona tuberosa. J. Nat. Prod. 2006, 69, 749–754. doi: 10.1021/np050539g

    13. [13]

      Jiang, R. W.; Ye, W. C.; Shaw, P. C.; But, P. P. H.; Mak, T. C. W. Absolute configuration of neostenine. J. Mol. Struct. 2010, 966, 18–22. doi: 10.1016/j.molstruc.2009.11.059

    14. [14]

      Xu, Y. T.; Hon, P. M.; Jiang, R. W.; Cheng, L.; Li, S. H.; Chan, Y. P.; Xu, H. X.; Shaw, P. C.; But, P. P. H. Antitussive effects of Stemona tuberosa with different chemical profiles. J. Ethnopharmacol. 2006, 108, 46–53. doi: 10.1016/j.jep.2006.04.022

    15. [15]

      Xu, Y. T.; Shaw, P. C.; Jiang, R. W.; Hon, P. M.; Chan, Y. M.; But, P. P. H. Antitussive and central respiratory depressant effects of Stemona tuberosa. J. Ethnopharmacol. 2010, 128, 679–684. doi: 10.1016/j.jep.2010.02.018

    16. [16]

      Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65, 55–63. doi: 10.1016/0022-1759(83)90303-4

    17. [17]

      Desiraju, G. R.; Steiner, T. The Weak Hydrogen Bond in Structural Chemistry and Biology. Oxford University Press, New York 1999.

    18. [18]

      Brem, B.; Seger, C.; Pacher, T.; Hofer, O.; Vajrodaya, S.; Greger, H. Feeding dterrence and cntact toxicity of stemona alkaloids, a source of potent natural insecticides. J. Agric. Food Chem. 2002, 50, 6383–6388. doi: 10.1021/jf0205615

  • Scheme 1  Structures of maistemonine (1) and isomaistemonine (2)

    Figure 1  HPLC chromatogram of total alkaloid of S. japonica, showing the presence of maistemonine (1) and the highest peak protostemonine. Column: C 18 column (Alltech, 250 × 4.6 cm, 5 μm); mobile phase: (A) H2O-(B) CH3CN containing 0.1% Et3N, gradient: 0~10 min isocratic 40% B, 10~12 min linear 40% to 50% of B; 12~28 min isocratic 50% B and 28~30 min linear 50% to 40% of B; flow rate: 1.0 mL/min; detection: 260 nm

    Figure 2  Molecular structure of 1, showing 30% probability displacement ellipsoids and the atom-numbering scheme

    Figure 3  A packing diagram for compound 1 viewed roughly down the a-axis. Selected hydrogen atoms highlight the scheme of hydrogen bonds

    Figure 4  Overlap of the natural 1 (with atom labels) and the synthetic compound with Olex 2 software. When overlapping A, B, C and D rings of the natural and synthetic compound, rings E from the two compounds are almost perpendicular to each other. For clarity, only ring E of the natural 1 was labeled

    Table 1.  Selected Bond Lengths (Å) and Bond Angles (°)

    Bond Dist. Bond Dist.
    O(1)–C(1) 1.199(3) O(5)–C(19) 1.208(4)
    O(2)–C(1) 1.365(3) O(6)–C(21) 1.334(3)
    O(2)–C(4) 1.453(3) O(6)–C(23) 1.434(4)
    O(3)–C(16) 1.218(4) N(1)–C(14) 1.455(3)
    O(4)–C(19) 1.374(4) N(1)–C(6) 1.460(3)
    O(4)–C(17) 1.430(3) N(1)–C(9) 1.466(3)
    Angle (°) Angle (°)
    C(14)–N(1)–C(6) 118.2(2) N(1)–C(9)–C(17) 113.2(2)
    C(14)–N(1–C(9) 120.6(2) C(10)–C(9)–C(17) 101.8(2)
    C(6)–N(1)–C(9) 111.8(2) C(8)–C(9)–C(17) 110.9(2)
    O(2)–C(4)–C(6) 111.4(2) C(15)–C(10)–C(11) 126.2(3)
    O(2)–C(4)–C(3) 103.6(2) C(15)–C(10)–C(9) 112.3(3)
    C(6)–C(4)–C(3) 114.3(2) C(11)–C(10)–C(9) 121.1(3)
    N(1)–C(6)–C(4) 113.8(2) O(4)–C(17)–C(21) 103.4(2)
    N(1)–C(6)–C(7) 104.1(2) O(4)–C(17)–C(16) 112.5(2)
    C(4)–C(6)–C(7) 108.4(2) C(21)–C(17)–C(16) 109.8(2)
    N(1)–C(9)–C(10) 117.7(2) O(4)–C(17)–C(9) 112.7(2)
    N(1)–C(9)–C(8) 104.3(2) C(21)–C(17)–C(9) 115.6(2)
    C(10)–C(9)–C(8) 109.0(2) C(16)–C(17)–C(9) 103.1(2)
    下载: 导出CSV

    Table 2.  Intermolecular C–H···O Interaction[17] Lengths (Å) and Angles (°)

    D–H···A d(D–H) d(H···A) d(D···A) ∠DHA
    C(14)–H(14A)···O(6) 0.97 2.36 3.147(4) 138
    C(14)–H(14B)···O(2) 0.97 2.36 3.070(4) 130
    C(3)–H(3A)···O(5)a 0.97 2.66 3.581(3) 159
    C(3)–H(3B)···O(3)b 0.97 2.73 3.494(4) 136
    C(22)–H(22A)···O(2)c 0.96 2.81 3.467(2) 126
    C(18)–H(18A)···O(1)d 0.96 2.72 3.430(3) 131
      Symmetry codes: (a) x – 1, y, z; (b) 1.5 – x, 1 – y, z – 0.5; (c) x + 1, y, z; (d) 1 – x, y + 0.5, 1.5 – z
    下载: 导出CSV
  • 加载中
计量
  • PDF下载量:  2
  • 文章访问数:  731
  • HTML全文浏览量:  21
文章相关
  • 发布日期:  2020-07-01
  • 收稿日期:  2019-12-11
  • 接受日期:  2020-03-05
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章